Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Targeted cancer therapies often cause serious skin problems that need careful management.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Voriconazole can cause serious side effects, especially in long-term use.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.